SCHEMBL7984876

SCHEMBL7984876

O=c1[nH]c(-c2ccccc2F)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 3/20 0.46
HPGD P15428 2/20 0.45
GLA P06280 1/20 0.44
HTT P42858 1/20 0.44
UBE2N P61088 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.43
ACP1 P24666 2/20 0.43
YTHDC1 Q96MU7 1/20 0.42
P2RX7 Q99572 1/20 0.41
MAPK1 P28482 1/20 0.40
GAA P10253 1/20 0.40
RCE1 Q9Y256 1/20 0.39
CXCR2 P25025 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974644 0.91 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7988452 0.90 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDUBE2N
SCHEMBL7974306 0.88 HPGD (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7988183 0.86 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7988662 0.85 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDGLA
SCHEMBL7985867 0.85 GAA (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDMEN1
SCHEMBL7988814 0.85 MAPK1 (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDGLA
SCHEMBL7974056 0.85 HPGD (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7973624 0.84 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1KMT2AHPGDGLA
SCHEMBL7987307 0.84 GRIN1 (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed